Filter
7857
Filtered Results: 7857
Text search:
drugs
act
Featured
Recommendations
658
New Publications
2025
Language
Document type
No document type
4750
Studies & Reports
1135
Guidelines
980
Manuals
343
Strategic & Response Plan
229
Fact sheets
169
Training Material
131
Situation Updates
39
Infographics
31
Brochures
22
Resource Platforms
17
Online Courses
7
Videos
2
Dashboards/Maps
1
App
1
Countries / Regions
India
467
Global
239
Kenya
229
South Africa
181
Uganda
162
Ethiopia
162
Nigeria
154
Western and Central Europe
154
Nepal
142
Sierra Leone
140
Liberia
122
Zambia
117
Malawi
113
Tanzania
113
Latin America and the Carribbean
109
Ghana
103
Africa
100
Bangladesh
98
Rwanda
97
Myanmar / Burma
95
Ukraine
87
Eastern Europe
75
Namibia
66
Philippines
65
Zimbabwe
57
Congo, Democratic Republic of
57
Russia
54
Indonesia
51
Senegal
50
Asia
50
South–East Asia Region
50
Syria
48
Cambodia
46
Lesotho
43
Burkina Faso
43
Mozambique
39
Germany
37
South Sudan
37
Botswana
35
Colombia
32
Brazil
30
Eswatini/ Swaziland
29
Haiti
26
Venezuela
26
West and Central Africa
26
Middle East and North Africa
24
East and Southern Africa
24
Cameroon
23
Guinea
21
Tajikistan
20
Benin
19
Peru
19
Eastern Europe and Central Asia
19
Paraguay
19
Argentina
19
Yemen
18
Chile
16
USA
16
Sudan
16
Afghanistan
15
Pakistan
15
Albania
14
Vietnam
13
Bolivia
12
Moldova
12
Georgia
12
Central African Republic
12
Thailand
11
Lebanon
11
Somalia
11
Madagascar
11
Laos
10
Mali
10
China
9
Armenia
9
Western Pacific Region
9
North Macedonia
8
Mexico
8
Ecuador
8
El Salvador
7
Sri Lanka
7
Niger
6
Jordan
6
North America
6
United Kingdom
6
Southern Africa
6
Palestine
6
Iraq
6
Turkey
5
Angola
5
Libya
5
Bhutan
5
Iran
4
Fiji
4
Kyrgyzstan
4
Uzbekistan
4
Burundi
4
Guinea-Bissau
4
Saudi Arabia
4
Jamaica
4
Spain
4
Côte d’Ivoire / Ivory Coast
4
Papua New Guinea
4
Egypt
4
Romania
4
Poland
4
Chad
4
Timor Leste/ East Timor
3
Serbia
3
Gambia
3
Kazakhstan
3
Morocco
3
Uruguay
3
Belarus
3
Djibouti
3
Greece
3
Canada
2
Singapore
2
Estonia
2
Mongolia
2
Qatar
2
Hungary
2
Lithuania
2
Gabon
2
Turkmenistan
2
Belgium
2
France
2
Mauritius
2
Tunisia
2
Portugal
2
Honduras
2
North Korea
1
Switzerland
1
Australia
1
Congo-Brazzaville
1
Bulgaria
1
Mauritania
1
Italy
1
Dominican Republic
1
Ireland
1
Japan
1
Denmark
1
Maldives
1
Norway
1
Azerbaijan
1
Latvia
1
Nicaragua
1
Solomon Islands
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
3053
Clinical Guidelines
674
Public Health
377
Women & Child Health
332
Key Resources
189
Capacity Building
132
Pharmacy & Technologies
85
Annual Report MEDBOX
2
Toolboxes
HIV
851
Mental Health
780
TB
667
COVID-19
446
AMR
341
Pharmacy
241
NTDs
216
Caregiver
180
NCDs
167
Rapid Response
148
Ebola
142
Conflict
122
Refugee
121
Planetary Health
121
Disability
116
Global Health Education
82
Natural Hazards
57
Health Financing Toolbox
57
Zika
36
Cholera
30
Specific Hazards
29
Polio
27
Social Ethics
25
South Sudan
2
Health Financing
1
This policy brief describes key HIV viral load thresholds and the available viral load testing approaches for monitoring how well antiretroviral therapy is working for people living with HIV. It provides clarification for and elaborates upon the current treatment monitoring algorithm from the Consol...
The 2018 global health financing report presents health spending data for all WHO Member States between 2000 and 2016 based on the SHA 2011 methodology. It shows a transformation trajectory for the global spending on health, with increasing domestic public funding and declining external financing. T...
Past quantitative research on health financing has focused mostly on the level and distribution of total expenditure, with little emphasis on the specific role of public funds, despite their known importance for universal health coverage (UHC). Health Accounts data do not disaggregate public expendi...
The waves of yellow fever transmission in the Region of the Americas in 2016–2018 involved the largest number of human and epizootic cases to be reported in several decades. Yellow fever is a serious viral hemorrhagic disease that poses a challenge for health professionals. It requires early recog...
This report compiles data for the first time on the far-reaching consequences of uncontrolled hypertension, including heart attacks, strokes and premature death, along with substantial economic losses for communities and countries. It also contains information on the global, regional and country-lev...
Trustworthy, evidence-based health guidelines form the basis of national policies affecting both patients and health-care workers. Emphasizing the link between robust evidence and people’s trust in their health systems, Dr Hans Henri P. Kluge, WHO Regional Director for Europe said at the launch ev...
Significant progress has been made in the eradication of three priority diseases in the African Region, as a result of extensive collaboration between the Regional Office, WHO country offices and countries. For example, in August 2020, the region was certified free of wild poliovirus. In the area of...
In In recent years, China has increased its international engagement in health. Nonetheless, the lack
of data on contributions has limited efforts to examine contributions from China. Existing estimates that track
development assistance for health (DAH) from China have relied primarily on one data...
Background: Cardiovascular disease (CVD), mainly heart attack and stroke, is the
leading cause of premature mortality in low and middle income countries (LMICs).
Identifying and managing individuals at high risk of CVD is an important strategy to prevent and control CVD, in addition to multisector...
Many features of the environment have been found to exert an important influence on cardiovascular disease (CVD) risk, progression, and severity. Changes in the environment due to migration to different geographic locations, modifications in lifestyle choices, and shifts in social policies and cultu...
Background: Atherosclerotic cardiovascular diseases (ASCVD) including myocardial infarction, stroke and peripheral arterial disease continue to be major causes of premature death, disability and healthcare expenditure globally. Preventing the accumulation of cholesterol-containing atherogenic lipopr...
The World Heart Federation (WHF) commenced a Roadmap initiative in 2015 to reduce the global burden of cardiovascular disease and resultant burgeoning of healthcare costs. Roadmaps provide a blueprint for implementation of priority solutions for the principal cardiovascular diseases leading to death...
Many low- and middle-income countries (LMICs) are undergoing an epidemiological transition. With an improvement in socioeconomic conditions and an aging population, cardiovascular diseases (CVDs), like cardiac arrhythmias, are expected to increase in these countries. However, there are limited studi...
Buruli ulcer (BU) is a bacterial skin infection that is caused by Mycobacterium ulcerans and mainly affects people who reside in the rural areas of Africa and in suburban and beach resort communities in Australia.
Global cardiovascular disease (CVD) burden is high and rising, especially in low-income and middle-income countries (LMICs). Focussing on 45 LMICs, we aimed to determine (1) the adult population’s median 10-year predicted CVD risk, including its variation within countries by socio-demographic char...
Approximately 80% of the 463 million adults worldwide with diabetes live in low-income and middle-income countries (LMICs). A major obstacle to designing evidence-based policies to improve diabetes outcomes in LMICs is the scarce availability of nationally representative data on the current patterns...
The evolving epidemic of type 2 diabetes mellitus has challenged health-care professionals. It stands among the leading causes of mortality in the present world. It warrants new and versatile approaches to improve mortality and the associated huge quality-adjusted life years lost to it once diagnose...
Cardiovascular diseases (CVDs) are a growing public health problem in Ghana and other African countries. Strokes and other CVDs have become a leading cause of death due to increasing risk factors such as hypertension. According to the Global Burden of Disease study (GBD), ischaemic heart disease was...
The document provides detailed clinical guidelines for the therapy of Type 1 Diabetes as developed by the German Diabetes Association (DDG). It focuses on individualized insulin therapy, structured patient training, and monitoring of blood glucose levels. The guidelines emphasize preventing complica...
WHO’s Country Cooperation Strategy (CCS) defines the Organization’s medium-term vision for working in and with a particular country. The CCS, developed in the context of global and national health priorities, examines the overall health situation in a country, including the state of the health s...
